TD Cowen made an adjustment to Danaher Corporation's (NYSE:DHR) financial outlook by reducing the price target from $315.00 to $260.00. Despite this change, the firm has maintained a Buy rating on the ...
Stifel analysts reduced the price target for Danaher Corporation shares (NYSE:DHR) to $260 from the previous target of $265, while maintaining a Hold rating on the stock. The new target sits within ...
U.S. stocks slipped after the Federal Reserve held its main interest rate steady and broke a run of cuts that began in ...
US stocks fall after the Fed held rates steady but suggested the inflation drop has stalled. Meta, Tesla and Microsoft report ...
Quarterly orders topped estimates, as companies scrambled to get their hands on machinery to make increasingly sophisticated semiconductors. U.S.-listed ASML sto ...
Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in ...
Danaher (DHR) stock trades ~5% lower as the company, with its Q4 2024 results, projects a sales contraction in the current ...
The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $2.17 per share. The industrial and medical device maker posted revenue of $6.54 billion in the period, ...
This positive outcome has rippled through the industry, with Danaher and Thermo Fisher anticipating their own earnings reports later this week. Analysts have weighed in on Sartorius's results, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback